2014 Hemostasis Gordon Research Conference and Gordon Research Seminar
2014 Hemostasis Gordon Research Conference and Gordon Research Seminar
批准号:
8784662
负责人:
Andrew S Weyrich
金额:
$1.25万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-15 至 2015-06-30
关键词:
AchievementAnimal ModelApplied ResearchAreaBasic ScienceBiochemistryBiologyBiotechnologyBlood Coagulation FactorBlood PlateletsBlood VesselsBlood coagulationCardiovascular DiseasesClinical ResearchCoagulation ProcessCommitCommunitiesDevelopmentDiagnosisDisciplineDiseaseEnsureEnvironmentEnzymatic BiochemistryEquilibriumFacultyFemaleFosteringFutureGeneticGoalsHealthHemorrhageHemostatic AgentsHemostatic functionHumanHuman GeneticsIndividualInfectionInflammationInternationalLinkMalignant NeoplasmsMedicalMedicineMinorityMolecular BiologyMusNaturePharmacologic SubstancePhysiciansPlayPostdoctoral FellowProcessProteinsResearchResearch PersonnelRoleRunningScientistSeriesSiteStudentsTalentsThrombosisTrainingTransgenic AnimalsTravelWomanWorkabstractingbasecatalystcostdisabilityexperiencehuman diseaseimprovedinnovationinterestmanmeetingspostersprogramspublic health relevancesocialstructural biologysuccesssymposiumtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
We request partial support for the Hemostasis Gordon Research Seminar (GRS) and Gordon Research Conference (GRC), which will be held at the GRC site in Waterville Valley, NH, July 26th through August 1st, 2014. The GRC meeting on hemostasis began in 1973 and has been held biennially since then. The 2014 conference represents the 32nd meeting in the series and is considered the premiere meeting for hemostasis-based research. The 2014 Hemostasis GRC meeting will be preceded by a GRS meeting dedicated to trainee development and exposure. The GRS meeting is organized and run by trainees, is highly successful, and enhances the profile of trainees at the GRC. The Hemostasis GRS/GRC brings together scientists interested in the biology, biochemistry and genetics of platelets and coagulation proteins, physicians involved in the treatment of bleeding and thrombotic diseases and investigators from small and large pharmaceutical companies developing new therapies for hemostatic disorders. The conference has legendary status establishing it as the forum at which cutting-edge research is presented and major advances in the field are unveiled. Indeed, some of the most spectacular recent achievements in hemostasis have been first unveiled at previous conferences in this series or have been driven by collaborative interactions fostered by this conference. The roster of invited speakers and discussion leaders who have agreed to participate in the GRS and GRC is impressive and represents top investigators in the field. These speakers and discussion leaders will enhance the stimulating nature of the environment for all attendees, especially junior
investigators and trainees. The 2014 Hemostasis GRS and GRC programs include heightened participation from women, minorities, and young investigators compared to previous conferences. Moreover, the 2014 meeting will include a significant number of attendees who are junior faculty, students, postdoctoral fellows and individuals with physical disabilities. The 2014
Hemostasis GRS program includes a keynote presentation from Dr. Jane Freedman, a very successful female physician-scientist, 12 presentations from trainees, and 40 poster discussions. The 2014 Hemostasis GRC program will have 4 poster gatherings and 8 presentation sessions that include: 1. The Vessel Wall in Thrombosis and Coagulation; 2. Thrombosis and Coagulation During Infection; 3. Platelets and Coagulation Factors in Development and Disease; 4. Crosstalk in the Vascular Milieu; 5. Links Between Thrombosis, Coagulation, and Inflammation; 6. Coagulation and Platelets in Disease; 7. Hot Topic Abstract Talks where 8 trainees present their work; and, 8. Defective Hemostasis. The conference will end on the evening of August 1st with a keynote session entitled "The Impact of Mouse and Human Genetics on Thrombosis and Hemostasis".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
-
批准号:10616557
-
项目类别:
-
资助金额:$71.22万
-
财政年份:2019
-
负责人:Andrew S Weyrich
-
依托单位:
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
-
批准号:10569253
-
项目类别:
-
资助金额:$73.09万
-
财政年份:2019
-
负责人:Andrew S Weyrich
-
依托单位:
Patient Enrollment and Data Analysis
-
批准号:8464249
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2013
-
负责人:Andrew S Weyrich
-
依托单位:
Platelet Reprogramming in Human Obesity and Diabetes
-
批准号:8464247
-
项目类别:
-
资助金额:$62.26万
-
财政年份:2013
-
负责人:Andrew S Weyrich
-
依托单位:
Administrative
-
批准号:8391960
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Platelet Reprogramming in Human Obesity and Diabetes
-
批准号:8391959
-
项目类别:
-
资助金额:$66.61万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8464229
-
项目类别:
-
资助金额:$252.4万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:9068226
-
项目类别:
-
资助金额:$252.7万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8656415
-
项目类别:
-
资助金额:$261.08万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8250544
-
项目类别:
-
资助金额:$266.69万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
The Molecular Regulation of Platelet Reprogramming by the Metabolic Milieu
-
批准号:8391955
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Metabolic Regulation of Platelet Reprogramming
-
批准号:8391957
-
项目类别:
-
资助金额:$34.26万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Human and Mouse Cell Isolation and Phenotyping
-
批准号:8391963
-
项目类别:
-
资助金额:$53.22万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
The Role of the Metabolic Milieu In Regulating Platelet Reprogramming in Humans
-
批准号:8391958
-
项目类别:
-
资助金额:$16.16万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Translational Research Skills Development Core
-
批准号:8392583
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Patient Enrollment and Data Analysis
-
批准号:8391962
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
PAR-04-122 Extramural Facilities Construction Grant. "F*
-
批准号:7000557
-
项目类别:
-
资助金额:$800.0万
-
财政年份:2010
-
负责人:Andrew S Weyrich
-
依托单位:
Reverse Transcriptase Activity in Megakaryocytes and Platelets
-
批准号:7845031
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
Novel Thrombotic and Inflammatory Activities of Platelets in Sepsis
-
批准号:7851203
-
项目类别:
-
资助金额:$52.82万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
Reverse Transcriptase Activity in Megakaryocytes and Platelets
-
批准号:7359528
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
海外基金